MigVax For Profit
MigVax, a SPV by MIGAL is developing a vaccine for COVID-19, Coronavirus in human.
Founded Date:
2020-01-01
Headquarters:
Misgav, HaZafon, Israel
Technology:
Drug development
Employee Number:
N/A
Industry:
PharmTech
Number Of Exists:
N/A
Funding Status:
N/A
Investor Type:
N/A
Investment Stage:
N/A